Gilead’s Triple-Drug Hepatitis C Regimen Works Well for Cirrhotic Genotype 3s
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The HepatitisC.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Gilead’s Triple-Drug Hep C Regimen Works Well for Cirrhotic Genotype 3s. (2016). Hep. Retrieved 26 February 2017, from https://www.hepmag.com/article/gileads-tripledrug-hep-c-regimen-works-cirrhotic-genotype-3s
- Highleyman, L. (2015). Gilead triple combination cures easy-to-treat hepatitis C patients in 6 weeks, but 4 weeks is not enough. Infohep.org. Retrieved 26 February 2017, from http://www.infohep.org/Gilead-triple-combination-cures-easy-to-treat-hepatitis-C-patients-in-6-weeks-but-4-weeks-is-not-enough/page/2968233/
- Le, T. & Wogen, J. (2003). Evaluation of hepatitis C genotype testing in newly diagnosed hepatitis C managed care patients. Hepatology, 38, 749-749. http://dx.doi.org/10.1016/s0270-9139(03)81262-4
- Nahass, R. (2016). Sofosbuvir/Velpatasvir Plus GS-9857(100MG) for 6, 8, or 12 Weeks in Genotype 1-6 HCV-Infected Patients: An Integrated Analysis of Safety and Efficacy from Two Phase 2 Studies. Idsa.confex.com. Retrieved 26 February 2017, from https://idsa.confex.com/idsa/2016/webprogram/Paper57008.html